Doylestown, PA, United States of America

Mary Doubleday

This inventor holds 3 USPTO granted patents. Top assignees: Signal Pharmaceuticals, Inc., Nippon Kayaku Co., Ltd. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Doubleday. Retrieved from https://idiyas.com/inventor/mary-doubleday

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Mary Doubleday

Introduction

Mary Doubleday is a notable inventor based in Doylestown, Pennsylvania, with a significant impact in the field of neuroprotection. With a total of three patents to her name, her work focuses on advancing medical technologies that have the potential to improve healthcare outcomes.

Latest Patents

Mary’s latest patents showcase her dedication to pioneering innovative solutions. These include:

1. Neuroprotective agents and methods related thereto

2. Compounds and methods for modulation of estrogen receptors

Career Highlights

Throughout her career, Mary has been associated with several esteemed organizations. Notably, she has worked with Signal Pharmaceuticals, Inc. and Nippon Kayaku Co., Ltd. Her roles in these companies have empowered her to contribute significantly to the development of innovative therapies.

Collaborations

Mary has collaborated with talented individuals in the industry, including Shripad S. Bhagwat and Bernd M. Stein. These partnerships have played a crucial role in enhancing her research and the advancements she has made in her field.

Conclusion

Mary Doubleday's contributions to innovation in neuroprotective agents and estrogen receptor modulation reflect her dedication and expertise as an inventor. Her work continues to inspire future developments in medicine, making a positive impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…